| Literature DB >> 35011342 |
Jamal Moideen Muthu Mohamed1, Ali Alqahtani2, Thankakan Vimala Ajay Kumar3, Adel Al Fatease4, Taha Alqahtani2, Venkatesan Krishnaraju2, Fazil Ahmad5, Farid Menaa6, Ali Alamri4, Ranjini Muthumani7, Rajendran Vijaya7.
Abstract
Green synthesis of silver nanoparticles (AgNPs) was synthesized from fresh garlic extract coupled with isoniazid hydrazide (INH), a commonly used antibiotic to treat tuberculosis. A molecular docking study conducted with the selected compounds compared with anthranilate phosphoribosyltransferase (trpD) from Mycobacterium tuberculosis. The aqueous extract of garlic was prepared and mixed with silver nitrate (AgNO3) solution for the superfast synthesis of stable AgNPs. INH was then conjugated with AgNPs at different ratios (v/v) to obtain stable INH-AgNPs conjugates (AgNCs). The resulting AgNCs characterized by FTIR spectra revealed the ultrafast formation of AgNPs (<5 s) and perfectly conjugated with INH. The shifting of λmax to longer wavelength, as found from UV spectral analysis, confirmed the formation of AgNCs, among which ideal formulations (F7, F10, and F13) have been pre-selected. The zeta particle size (PS) and the zeta potential (ZP) of AgNPs were found to be 145.3 ± 2.1 nm and -33.1 mV, respectively. These data were significantly different compared to that of AgNCs (160 ± 2.7 nm and -14.4 mV for F7; 208.9 ± 2.9 nm and -19.8 mV for F10; and 281.3 ± 3.6 nm and -19.5 mV for F13), most probably due to INH conjugation. The results of XRD, SEM and EDX confirmed the formation of AgNCs. From UV spectral analysis, EE of INH as 51.6 ± 5.21, 53.6 ± 6.88, and 70.01 ± 7.11 %, for F7, F10, and F13, respectively. The stability of the three formulations was confirmed in various physiological conditions. Drug was released in a sustainable fashion. Besides, from the preferred 23 compounds, five compounds namely Sativoside R2, Degalactotigonin, Proto-desgalactotigonin, Eruboside B and Sativoside R1 showed a better docking score than trpD, and therefore may help in promoting anti-tubercular activity.Entities:
Keywords: garlic extract; green synthesis; isoniazid hydrazide; molecular docking; nanoconjugates; silver nanoparticles
Mesh:
Substances:
Year: 2021 PMID: 35011342 PMCID: PMC8746848 DOI: 10.3390/molecules27010110
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1UV-Visible spectrum in the range 200–800 nm of (a) INH, (b) AgNPs, (c) F7, (d) F10, and (e) F13 λmax is indicated in each spectrum.
Figure 2Calibration graph of INH at λmax 263 nm.
Figure 3The FTIR spectrum of (a) Garlic extract, (b) AgNPs, (c) INH, (d) F7, (e) F10, and (f) F13.
The FTIR spectrum wavenumbers and its concern bands of samples.
| Sample | Wavenumber | Band | Characteristic Function |
|---|---|---|---|
| Garlic Extracts | 3455.81, 2884.02, 1644.02, 1407.78, 1132.97, 1032.69, 932.414, 617.109, 490.795 | 3584–3700 | –OH Stretching |
| AGNPS | 3778.83, 2962.13, 2885.95, 2808.81, 1579.41, 1394.28, 1087.66, 840.812, 615.818, 485.974 | 2800–3000 | N-H Stretching |
| INH | 3774.01, 3665.05, 3304.43, 3235, 3113.51, 3002.62, 2873.42, 2664.18, 1957.39, 1669.2, 1554.34, 1409.71, 1330.64, 1217.83, 1135.87, 1057.76, 995.089, 889.023, 844.669, 745.352, 668.214, 499.473, 434.869 | 2850–2975 | Alkane Group |
| F7 | 3677.59, 3428.81, 3331.43, 3055.66, 2998.77, 2946.7, 2963.56, 2884.99, 2836.77, 2818.45, 2766.39, 2676.71, 2290.05, 1780.94, 1701.87, 1557.24, 1497.45, 1426.1, 1327.75, 1275.68, 1211.08, 1025.94, 883.238, 771.387, 706.783, 674.963 | 1210–1163 | C=O Stretching |
| F10 | 3677.59, 3427.85, 3331.43, 3219.58, 3053.73, 2939.95, 2887.88, 2830.99, 2673.82, 1854.22, 1753.94, 1702.84, 1555.31, 1496.49, 1424.17, 1326.79, 1209.15, 1036.55, 883.238, 772.351, 672.071 | 700–900 | C-H Bending |
| F13 | 3697.84, 3430.74, 3013.23, 2931.27, 2886.92, 2819.42, 2675.75, 2529.18, 1878.33, 1752.01, 1698.98, 1550.49, 1495.53, 1424.17, 1327.75, 1210.11, 1040.41, 880.345, 783.922, 673.035, 456.082 | 730–665 | C=C Bending |
Figure 4XRD spectrum of AgNPs synthesized from Allium sativum (garlic).
Figure 5HR-TEM images of AgNCs at (a) bar scale of 100 nm, (b) bar scale of 2 nm.
Figure 6In vitro release of INH from garlic-mediated synthesized AgNCs at 37 °C either at pH 5.7 or pH 7.2. Free INH in 1X PBS was used as control.
In vitro release kinetics of SLN (Data are expressed as mean ± SD, n = 3).
| Correlation Coefficient (r2) | ||||||
|---|---|---|---|---|---|---|
| F #13 | Zero-Order | First Order | Higuchi | Hixon Crowell | Korsmeyer-Peppas | Release Exponent ( |
| Free INH (pH 5.7) | 0.965 ± 0.13 | 0.976 ± 0.36 | 0.984 ± 0.31 | 0.991 ± 0.12 | 0.88 ± 0.19 | 7.8 ± 0.32 |
| Free INH (pH 7.2) | 0.957 ± 0.13 | 0.994 ± 0.36 | 0.986 ± 0.31 | 0.990 ± 0.15 | 0.89 ± 0.18 | 6.4 ± 0.32 |
| AgNCs (pH 5.7) | 0.986 ± 0.17 | 0.994 ± 0.22 | 0.964 ± 0.33 | 0.993 ± 0.16 | 0.834 ± 0.27 | 4.98 ± 0.67 |
| AgNCs (pH 7.2) | 0.841 ± 0.17 | 0.993 ± 0.22 | 0.965 ± 0.33 | 0.991 ± 0.18 | 0.950 ± 0.22 | 0.115 ± 0.67 |
F: Formulation; INH: Isoniazid hydrazide; AgNCs: Silver nanoconjugates (AgNPs + INH).
Figure 7In vitro stability evaluated by UV–Vis spectrophotometry at room temperature for (a) AgNCs exposed to 1X PBS for 48 h at indicated pH, and normal saline (0.9% NaCl); (b) AgNPs and conjugated with INH.
The docking score, Glide evdw (Van Der Waals energy), ecoul (Coulomb energy), interacting residues and the type of interaction of 23 bioactive compounds with the protein anthranilate phosphoribosyltransferase (trpD). The docking scores calculated using Glide program of Schrodinger Maestro (version 2018.1).
| Target Protein | Name of the Compound | Docking Score | Glide Evdw | Glide Ecoul | Glide Energy | Interacting Residues |
|---|---|---|---|---|---|---|
| 3R6C | 2-Vinyl-4H-1,3-dithiine | −2.99 | −22.86 | −1.82 | −24.67 | - |
| Agapanthagenin | −3.99 | −20.09 | −6.95 | −27.03 | ALA334 | |
| Ajoene | −1.86 | −22.85 | −5.86 | −28.71 | HOH749 | |
| Allicin | −2.37 | −17.87 | −8.36 | −26.23 | HOH749 | |
| Allitridin | −0.99 | −17.81 | −1.40 | −19.21 | - | |
| Allyl methyl disulfide | −1.98 | −18.93 | −1.39 | −20.31 | - | |
| Beta-Chlorogenin | −3.30 | −28.67 | −2.28 | −30.96 | HOH618 | |
| Degalactotigonin | −10.13 | −30.24 | −21.80 | −52.04 | SER268, VAL325, SER332 and ALA334 | |
| Diallyl disulfide | −1.64 | −21.25 | −2.02 | −23.27 | - | |
| Diallyl sulfide | −1.10 | −18.85 | −1.72 | −20.57 | - | |
| Diallyl thiosulfonate | −2.40 | −23.11 | −4.31 | −27.42 | ARG263 | |
| Diallyl trisulfide | −0.99 | −17.81 | −1.40 | −19.21 | - | |
| Diosgenin | −2.60 | −21.36 | −4.09 | −25.45 | ALA334 | |
| Eruboside B | −8.61 | −26.07 | −18.93 | −44.99 | SER268, ASP270, SER332, ALA334, TRP336 and HOH618 | |
| Gitogenin | −3.27 | −22.20 | −3.98 | −26.17 | ALA334 | |
| Proto-desgalactotigonin | −8.05 | −24.65 | −17.87 | −42.52 | ASP270, LEU272, ALA334, HOH777 | |
| Protoeruboside B | - | - | - | - | - | |
| S-allyl-cysteine sulfoxide | −3.15 | −16.07 | −12.32 | −28.39 | ARG263, ALS334, TRP336, HOH749, | |
| S-allyl-cysteine | −2.80 | −15.19 | −13.07 | −28.26 | ALS334, GLU335, TRP336, HOH749 | |
| Sativoside B1 | - | - | - | - | - | |
| Sativoside R1 | −7.10 | −7.55 | −13.43 | −20.99 | ALA266, SER332 and HOH618 | |
| Sativoside R2 | −11.04 | −15.81 | −17.35 | −33.15 | ARG263, SER268, ALA334, HOH654 | |
| S-Methyl-L-cysteine | −2.48 | −13.25 | −11.01 | −24.26 | ARG263, ALA334, TRP336 and HOH749 |
HB—Hydrogen bonding; Pi-Pi—π-π bond.
Figure 8Sativoside R2 (a), Degalactotigonin (b), and Eruboside B (c) interaction map with the protein anthranilate phosphoribosyltransferase (3R6C); Proto-Degalactotigonin (d), and Sativoside R1 (e) interaction map with the protein Anthranilate phosphoribosyltransferase (3R6C).
λmax and absorbance values of AgNCs at various compositions (v/v).
| #F | AgNCs | Trial 1 | Trial 2 | Trial 3 | ||||
|---|---|---|---|---|---|---|---|---|
| - | INH (μL) | AgNPs (μL) | λmax | Abs | λmax | Abs | λmax | Abs |
| 1 | 100 | 0 | 262 | 0.020 | 263 | 0.031 | 261 | 0.031 |
| 2 | 0 | 100 | 415 | 0.016 | 413 | 0.018 | 412 | 0.015 |
| 3 | 100 | 100 | 266 | 0.024 | 261 | 0.029 | 259 | 0.098 |
| 4 | 100 | 900 | 274 | 0.051 | 343 | 0.019 | 259 | 0.060 |
| 5 | 200 | 800 | 355 | 0.015 | 356 | 0.020 | 259 | 0.057 |
| 6 | 300 | 700 | 259 | 0.051 | 259 | 0.051 | 383 | 0.042 |
| 7 |
|
|
|
|
|
|
| 0.045 |
| 8 | 500 | 500 | 270 | 0.055 | 261 | 0.034 | 352 | 0.026 |
| 9 | 600 | 400 | 260 | 0.043 | 259 | 0.038 | 261 | 0.132 |
| 10 |
|
|
|
|
|
|
| 0.036 |
| 11 | 800 | 200 | 264 | 0.025 | 267 | 0.044 | 259 | 0.041 |
| 12 | 900 | 100 | 264 | 0.049 | 341 | 0.024 | 259 | 0.078 |
|
|
|
|
|
|
|
|
|
|
F: Formulation; INH: Isoniazid hydrazide; AgNPs: Silver nanoparticles; AgNCs—Silver nanoconjugates; λmax: Maximal wavelength; Abs: Absorbance.
List of bioactive compounds present in Allium sativa (garlic).
| Name of the Compound | PubChem/ACS/Fooddb | Name of the Compound | PubChem/ACS/Fooddb | ||
|---|---|---|---|---|---|
| 1 | 2-Vinyl-4H-1,3-dithiine | 133337 | 13 | Diosgenin | 99474 |
| 2 | Agapanthagenin | 15558507 | 14 | Eruboside B | 13787750 |
| 3 | Ajoene | 5386591 | 15 | Gitogenin | 441887 |
| 4 | Allicin | 65036 | 16 | Proto-degalactotigonin | 14464370 |
| 5 | Allitridin | 16315 | 17 | Protoeruboside B | FDB003677 |
| 6 | Allyl methyl disulfide | 62434 | 18 | S-allyl-cysteine sulfoxide | 15558642 |
| 7 | Beta-Chlorogenin | 10717615 | 19 | S-allyl-cysteine | 9793905 |
| 8 | Degalactotigonin | 162401 | 20 | Sativoside B1 | 14464368 |
| 9 | Diallyl disulfide | 16590 | 21 | Sativoside R1 | 131752731 |
| 10 | Diallyl sulfide | 11617 | 22 | Sativoside R2 | 3474285 |
| 11 | Diallyl thiosulfonate | 88093432 | 23 | S-Methyl-L-cysteine | 24417 |
| 12 | Diallyl trisulfide | 16315 |
Figure 9The bioactive compounds from Allium sativum (garlic) and their chemical structures.
Figure 10The bioactive compounds from Allium sativum (garlic) and their chemical structures.